✦ LIBER ✦

Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

✍ Scribed by Hsiao, Liang-Tsai; Tien, Hwei-Fang; Kuo, Ching-Yuan; Wu, Jin-Hou; Hou, Hsin-An; Wang, Ming-Chung; Liu, Chun-Yu; Chen, Po-Min; Chiou, Tzeon-Jye

Book ID: 125990151
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 212 KB
Volume: 33
Category: Article
ISSN: 0278-0232
DOI: 10.1002/hon.2161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of ben

Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

✍ Michinori Ogura; Toshiki Uchida; Masafumi Taniwaki; Kiyoshi Ando; Takashi Watana 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Phase II Multicenter Study of Bendamusti

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

✍ Robinson, K. S.; Williams, M. E.; van der Jagt, R. H.; Cohen, P.; Herst, J. A.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 119 KB

Phase I/II study of 2-chloro-2′-deoxyade

Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin’s lymphoma

✍ Van Den Neste, E; Louviaux, I; Michaux, J L; Delannoy, A; Michaux, L; Sonet, A; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Safety and feasibility of CHOP/rituximab

Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma

✍ Heß, G; Flohr, T; Huber, C; Kolbe, K; Derigs, H-G; Fischer, T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB